Novolin is the brand name of three distinct insulin-containing products[1] manufactured by Novo Nordisk:[2]
- Novolin 70/30, an insulin preparation containing mixed NPH and regular insulin, respectively
- Novolin N, an insulin preparation containing NPH insulin
- Novolin R, an insulin preparation containing regular insulin
References
edit- ^ "Novolin N Uses, Side Effects & Warnings". Drugs.com. Retrieved 4 May 2022.
- ^ Landgraf W, Sandow J (March 2016). "Recombinant Human Insulins - Clinical Efficacy and Safety in Diabetes Therapy". European Endocrinology. 12 (1): 12–17. doi:10.17925/EE.2016.12.01.12. PMC 5813452. PMID 29632581.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |